Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 11, 2024Open Access

Immunotherapy in Type 1 Diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

MKMohammad Amin KeikhanejadZahedan University of Medical Sciences

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mohammad Amin Keikhanejad (2024) studied this question.

synapsesocial.com/papers/68e65549b6db6435875e41d1https://doi.org/10.31234/osf.io/6bdct
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Historically Based Perspective on the Immunotherapy of Type 1 Diabetes: Where We Have Been, Where We Are, and Where We May Go2025 · 3 citations
  2. 2Type 1 diabetes mellitus: retrospect and prospect2024 · 14 citations
  3. 3Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways2024 · 6 citations
  4. 4New and emerging therapies in type 1 diabetes mellitus.2026 · 2 citations
  5. 5Emerging therapies for type 1 diabetes: Immunotherapy and gene editing advances.2026